Targeted Antibiotics for Trachoma: A Cluster-Randomized Trial
Author(s) -
Jason Melo,
Solomon Aragie,
Ambahun Chernet,
Zerihun Tadesse,
Adane Dagnew,
Dagnachew Hailu,
Mahteme Haile,
Tàye Zeru,
Dionna M. Wittberg,
Scott D. Nash,
E. Kelly Callahan,
Benjamin F. Arnold,
Travis C. Porco,
Thomas M. Lietman,
Jeremy D. Keenan
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab193
Subject(s) - trachoma , medicine , antibiotics , randomized controlled trial , cluster randomised controlled trial , intensive care medicine , microbiology and biotechnology , pathology , biology
Current guidelines recommend community-wide mass azithromycin for trachoma, but a targeted treatment strategy could reduce the volume of antibiotics required.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom